Youn Joo Jung, Dong-Young Lee, Hae Won Kim, Hyun Sun Park, Beom Kim
{"title":"A Case Report of Syndrome of Inappropriate Antidiuretic Hormone Induced by Pregabalin.","authors":"Youn Joo Jung, Dong-Young Lee, Hae Won Kim, Hyun Sun Park, Beom Kim","doi":"10.5049/EBP.2016.14.2.31","DOIUrl":null,"url":null,"abstract":"<p><p>The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most common cause of euvolemic hyponatremia, and many medications have been associated with SIADH. Pregabalin is a drug used for the treatment of neuropathic pain, though common adverse effects include central nervous system disturbance, peripheral edema, and weight gain. However, hyponatremia caused by pregabalin has been rarely reported. Here we report a patient with pregabalin-induced hyponatremia who met the criteria for SIADH; after discontinuation of the drug, his condition rapidly improved. This case can help clinicians diagnose and treat new-onset hyponatremia in patients who recently initiated pregabalin therapy.</p>","PeriodicalId":35352,"journal":{"name":"Electrolyte and Blood Pressure","volume":"14 2","pages":"31-34"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5049/EBP.2016.14.2.31","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Electrolyte and Blood Pressure","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5049/EBP.2016.14.2.31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/12/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 7
Abstract
The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most common cause of euvolemic hyponatremia, and many medications have been associated with SIADH. Pregabalin is a drug used for the treatment of neuropathic pain, though common adverse effects include central nervous system disturbance, peripheral edema, and weight gain. However, hyponatremia caused by pregabalin has been rarely reported. Here we report a patient with pregabalin-induced hyponatremia who met the criteria for SIADH; after discontinuation of the drug, his condition rapidly improved. This case can help clinicians diagnose and treat new-onset hyponatremia in patients who recently initiated pregabalin therapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
